Contreras AM, Monteón FJ, Flores MR, Mendoza-Sánchez F, Ruiz I

Idioma: Ingles.
Referencias bibliográficas: 20
Paginas: 70-73
Archivo PDF: 180.47 Kb.

FRAGMENTO

No tiene resumen

REFERENCIAS (EN ESTE ARTÍCULO)

1. Fabrizi F, Martin P, Ponticelli C. Hepatitis C virus infection and renal transplantation. Am J Kidney Dis 2001; 38(5): 919–34.

2. Russo MW, Jacobson IM. How to use statins in patients with chronic liver disease. Cleve Clin J Med 2004; 71(1): 58–62.

3. Pol S, Cavalcanti R, Carnot F, Legendre C, Driss F, Chaix ML, Thervet E, et al. Azathioprine hepatitis in kidney transplant recipients. A predisposing role of chronic viral hepatitis. Transplantation 1996; 61(12): 1774–6.

4. Bellosta S, Paoletti R, Corsini A. Safety of statins. Focus on clinical pharmacokinetics and drug interactions. Circulation 2004; 109[suppl III]: 50–7.

5. Pol S, Debure A, Degott C, Carnot F, Legendre C, Brechot C, Kreis H. Chronic hepatitis in kidney allograft recipients. Lancet 1990; 335: 878–80.

6. Morales JM, Campistol JM. Transplantation in the patient with hepatitis C. J Am Soc Nephrol 2000; 11: 1343–53.

7. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G. Hepatitis C virus antibody status and survival after renal transplantation: Meta-analysis of observational studies. Am J Transplant 2005; 5: 1452–61.

8. Rao KV, Anderson WR. Liver disease after renal transplantation. Am J Kidney Dis 1992; 19(5): 496–501.

9. Hanafusa T, Ichikawa Y, Kishikawa H, Kyo M, Fukunishi T, Kokado Y, Okuyama A, et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 1998; 66(4): 471–6.

10. Contreras AM, Chung RT. Hepatitis C virus in solid organ transplantation: not always a bad thing? Gastroenterology 2002; 123(5): 1729–33.

11. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH. Hepatitis C and renal disease: an update. Am J Kidney Dis 2003; 42(4): 631–57.

12. Zylberberg H, Nalpas B, Carnot F, Skhiri H, Fontaine H, Legendre C, Kreis H, et al. Severe evolution of chronic hepatitis C in renal transplantation: a case control study. Nephrol Dial Transplant 2002; 17: 129–33.

13. Perez RM, Ferreira AS, Medina-Pestana JO, Cendoroglo-Neto M, Lanzoni VP, Silva AE, Ferraz ML. Is hepatitis C more aggressive in renal transplant patients than in patients with end-stage renal disease? J Clin Gastroenterol 2006; 40(5): 444–8.

14. Monteon FJ, Gomez B, Valdespino C, Chavez S, Sandoval M, Flores A, Herrera R, et al. The kidney transplant experience at Hospital de Especialidades, Centro Médico Nacional de Occidente, IMSS, Guadalajara México. In: Cecka JM, Terasaki P, eds. Clinical Transplants 2003. UCLA Immunogenetics Center, Los Angeles: UCLA Immunogenetics Center, 2003: 165–74.

15. Einollahi B, Hajarizadeh B, Bakhtiari S, Lesanpezeshki M, Reza-Khatami M, Hossein-Nourbala M, Pourfarziani V, et al. Pretransplant hepatitis C virus infection and its effect on the post-transplant course of living renal allograft recipients. J Gastroen Hepatol 2003; 18(7): 836–40.

16. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998; 47(No. RR-19): 1.

17. Suthanthiran M, Strom TB. Renal transplantation. N Engl J Med 1994; 331(6): 365–76.

18. Breitenfeldt MK, Rasenack J, Berthold H, Olschewski M, Schroff J, Strey C, Grotz WH. Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation. Clinical Transplant 2002; 16(2): 130–6.

19. Meier-Kriesche HU, Ojo AO, Hanson JA, Kaplan B. Hepatitis C antibody status and outcomes in renal transplant recipients. Transplantation 2001; 72(2): 241–4.

20. Monteón FJ, Contreras AM, Espinoza L, Vazquez G, Aguilar S, Cueva L. Interferon Alfa-2b in renal transplant recipients with viral chronic hepatitis: A pilot study. Transplant Proc 1996; 28(6): 3306–08.